Of particular interest is that vGluT2+/TH+ midbrain dopamine neurons and their axon terminals in the striatum have been shown to be more resilient to neurodegeneration in postmortem PD brains and animal models studies (Buck et al., 2021; Steinkellner et al., 2022). This evidence concerns the gene SLC17A6 and Parkinson disease.